MTOR and plasma cell myeloma: As shown in Fig. 4e and f, mTOR phosphorylation at Ser2481 (which is a marker of mTORC2 activation) was downregulated, leading to downstream repression of AKT phosphorylation at Ser473 and ultimately, to the inhibition of the myeloma cell growths.